Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a ‘Case Study’

Agata Ptaszynska, Samuel M. Cohen, Edward M. Messing, Timothy P. Reilly, Eva Johnsson, Kristina Johnsson

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Fingerprint Dive into the research topics of 'Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a ‘Case Study’'. Together they form a unique fingerprint.

Medicine & Life Sciences